YOLFTbeta
10

Aprogen Healthcare & Games Inc

109960 · KQ · Healthcare / Pharmaceuticals

1,656.00KRW+2.00 (+0.12%)

Price History

Full chart

Market Stats

Previous Close1,654.00
Open1,655.00
Day Range1,635.00 – 1,695.00
52-Week Range1,430.00 – 6,600.00
Volume1.10K
Market Cap28.47B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.14
50-Day Avg1,792.08
200-Day Avg2,987.82

About

Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for streetlights/security lamps, and Bluetooth hands-free for vehicles; rents bio equipment; and leases real estate properties. In addition, it provides mobile games, such as Dragon Raja M, Legend of super heroes, Heroes & Titans, and Flame shadow. The company was formerly known as Locojoy International Corporation. Aprogen Healthcare & Games Inc. was founded in 1998 and is headquartered in Seongnam, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Chang-Yong Jung
  • Employees17
  • HeadquartersHalla Sigma Valley B1, Seongnam-si, South Korea, Korea
  • Websitehttps://www.aprogen-hng.com

Leadership

  • Mr. Chang-Yong JungSr. Managing Director and Director of Light Control Division · b. 1967
  • Mr. Jang-Woon ParkChief of R&D Center and Managing Director · b. 1967
  • Mr. Yu-Chan KimManaging Director and Director of Management Support Division · b. 1970
  • Mr. Hui ChangChief Exec. Officer · b. 1965
  • Mr. Jung-Gwon LeeSr. Managing Director and Director of Wireless Solution Bus. Division · b. 1967

Financials

Income Statement

Currency: KRW2013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue20.70B11.12B9.82B11.24B17.58B21.90B10.32B8.42B9.60B16.01B16.40B9.81B
Growth (%)--46.30%-11.65%+14.47%+56.37%+24.58%-52.88%-18.44%+14.04%+66.77%+2.46%-40.20%
Cost of Revenue17.15B8.21B10.20B8.60B12.58B15.36B7.83B6.65B7.47B11.03B11.04B8.33B
Gross Profit3.14B2.91B-379.54M2.64B5.00B6.54B2.49B1.76B2.13B4.98B5.36B1.48B
Gross Margin15.16%26.18%-3.86%23.51%28.46%29.87%24.09%20.94%22.19%31.12%32.71%15.07%
Operating Expense5.53B5.13B17.36B7.10B6.29B11.44B6.70B4.44B3.06B9.15B4.40B927.32M
Operating Income-2.39B-2.22B-17.74B-4.46B-1.29B-4.90B-4.21B-2.68B-930.46M-4.17B966.61M551.02M
Operating Margin-11.53%-19.95%-180.60%-39.67%-7.34%-22.36%-40.79%-31.79%-9.69%-26.07%5.89%5.62%
EBITDA--------3.13B8.26B-21.04B-5.21B
EBITDA Margin--------32.61%51.57%-128.32%-53.09%
Net Income-3.67B-2.56B-22.75B-3.30B8.74B-6.75B11.08B2.65B-5.61B4.30B-28.09B-5.56B
Net Income Margin-17.72%-22.99%-231.64%-29.35%49.72%-30.84%107.42%31.49%-58.41%26.89%-171.30%-56.69%
R&D1.29B97.04M17.94M------794.25M782.82M492.50M
R&D as % of Total Revenue6.24%0.87%0.18%------4.96%4.77%5.02%
Interest Expense00000012.22M6.72M64.40M2.13B4.87B854.27M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.12%0.08%0.67%13.29%29.67%8.71%

Balance Sheet

Currency: KRW2013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.11B27.11B15.61B141.75B237.93B218.36B236.89B226.74B213.39B316.56B334.89B320.46B
Total Liabilities7.71B12.03B6.97B26.94B20.47B7.87B5.06B4.13B14.51B29.29B33.08B13.89B
Total Equity4.40B15.08B8.64B114.81B217.46B210.50B231.83B222.62B198.89B287.30B301.81B306.59B
Cash1.99B19.21B5.78B17.42B10.03B17.55B31.70B11.53B74.00K9.22B4.69B4.13B
Total Debt-10.29B381.25M16.84B-1.19B444.96M-----
Net Debt---------4.41B12.85B2.05B

Cash Flow

Currency: KRW2013-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow1.22B-1.97B-9.71B734.70M4.36B986.07M3.39B-13.29B17.28B1.66B4.71B2.44B
Investing Cash Flow-919.69M-118.99M-11.19B-113.23B-98.34B17.96B11.02B-6.79B-18.47B-97.25B-51.92B-
Financing Cash Flow331.45M19.90B7.44B124.14B86.59B-11.44B-225.68M-95.59M5.46B89.00B42.69B-
Capital Expenditure399.12M164.12M303.16M10.87B42.13M96.26M29.97M5.72M024.98M81.90M14.09M
Free Cash Flow------3.36B-13.71B17.28B1.63B4.63B2.42B
FCF to OCF------99.11%103.18%100.00%98.32%98.26%99.42%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016May 15, 2017Aug 14, 2017Nov 13, 2017Feb 9, 2018May 14, 2018Aug 14, 2018Nov 14, 2018Jan 31, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Jan 28, 2020May 15, 2020Aug 13, 2020Nov 13, 2020Feb 5, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------
EPS Actual1666.67976.00-4291.672728.69-2949.20-4387.78-2314.36-6770.67-1907.111150.00-2551.28-308.01-3037.391201.52-1761.99-13206.11-2932.75-1125.551059.142080.2932.67-417.65-10750.00-3766.46-13322.92-5491.51-7727.84-31925.15-44.2318.86-7.07-135.404.9275.33336.80-153.94-286.50105.7927.30-7.15-5.0030.0029.0037.0589.11-151.86121.491425.52763.06555.021012.76-5471.1952200.64121.651892.27-3575.988309.56-4810.302901.93-6437.53-119.6114.80-105.45-303.01-310.613410.89
Surprise------------------------------------------------------------------
Timing----------------------------Pre-marketPre-marketAfter-hours-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market----------------------

Key Statistics & Ratios

Market Cap28.47B
Enterprise Value17.36B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.85
Price / Book0.08
Revenue (TTM)9.00B
Gross Profit (TTM)1.71B
EBITDA-1.00B
Profit Margin74.49%
Operating Margin-14.43%
Return on Equity-2414.97%
Return on Assets-0.36%
Shares Outstanding178.70M
Shares Float71.86M
Beta1.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 1, 20261:20
  • Apr 7, 20231:5
  • Jun 15, 20182:1
  • Aug 31, 2015959692:319897
  • Dec 29, 20102:1